All sales in an emerging company are going to be lumpy for multiple reasons.
DRO is very similar to a lot of life science stocks as they navigate sales into hospitals. Big pharma and the industrial military complex don't like companies taking market share
Buying and selling on one quarterly or the anticipation is just an attempt to create a perception around these notions and are just tactics used by disgruntled and failed investors, shorters, or days traders.
Millions of dollars are transacted on the share daily and we've seen it increase 300% over 6 months, do you really think the opinions of failed investors anticipating sales are anything else other than self interest?
All sales in an emerging company are going to be lumpy for...
Add DRO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
82.5¢ |
Change
0.030(3.77%) |
Mkt cap ! $581.1M | |||
| Open | High | Low | Value | Volume |
| 80.5¢ | 84.0¢ | 80.5¢ | $10.94M | 13.32M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 200000 | 90.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 20137 | 1 |
View Market Depth
| Last trade - 15.59pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
82.0¢ |
Change
0.030 ( 4.43 %) |
||||
| Open | High | Low | Volume | ||
| 80.5¢ | 84.0¢ | 80.5¢ | 4807875 | ||
| Last updated 15.59pm 30/04/2024 ? | |||||
| DRO (ASX) Chart |